- Symbol
- 2BIIB
- Segment MIC
- MTAH
- ISIN
- US09062X1037
- Trading currency
- EUR
MTAH:2BIIB — listed on BORSA ITALIANA - TRADING AFTER HOURS
Biogen Inc. is a biotechnology company that specializes in the development and commercialization of therapies for neurological and neurodegenerative diseases. Its product portfolio includes treatments for conditions such as multiple sclerosis, spinal muscular atrophy, and amyotrophic lateral sclerosis. Biogen operates globally, with a focus on research and innovation in the life sciences sector, and collaborates with various partners to enhance its therapeutic offerings. The company serves patients, healthcare providers, and researchers across multiple regions, including the United States and Europe.